Benzinga.com

Medtronic's New Implant Could Transform Bladder Control Treatment

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
Star Tribune

Medtronic ratchets up patent spat for device that aids in bladder, bowel control

Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
Seeking Alpha

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
Nasdaq

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
The Courier-Mail

This Aussie medtech is taking aim at a US bladder-control stronghold

Medtech giants Boston Scientific and Medtronic are doubling down on bladder-control therapies, confirming this space as one of the sector’s fastest-growing battlegrounds. Australis Scientific is ...